Available Brands
Did you find this information helpful?
Author Details

Written By
P. Thirumal Reddy
B. Pharm

Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 26 Sep 2026 | 08:41 AM (IST)

Want to know more?
Read Our Editorial Policy
Quick Summary
TISLELIZUMAB
Last updated on 26 Sep 2026 | 08:41 AM (IST)
TISLELIZUMAB
Background and Date of Approval
Tislelizumab is a new type of cancer medicine that helps the body’s own immune system find and fight cancer cells. It’s part of a class of treatments called immunotherapy, and it's designed to treat various types of cancer such as lung cancer, head and neck cancer, liver cancer, and bladder cancer, among others.
It was first approved in China in 2019 and is currently being used globally through clinical trials and regulatory approvals for the treatment of specific cancers. In India, it is made available through authorized oncology treatment programs and specialists.
Uses
Tislelizumab is used to treat several cancers, especially when:
-
The cancer has spread or come back after earlier treatments
-
Standard chemotherapy or radiation therapy hasn’t worked well.
-
The cancer is in organs like the lungs, liver, bladder, or head and neck area.
Doctors choose this medicine based on the specific type of cancer and the stage of the disease.
How It Works
Our immune system typically fights infections and diseases, but cancer cells often evade detection and hide from the body. Tislelizumab removes this “shield” from cancer cells so the immune system can recognize and attack them.
It works by activating your body’s natural defense and helps it stay alert against the cancer. It does not attack cancer directly like chemotherapy, but guides the immune system to do the job.
Drug Administration and Dosage Available
Tislelizumab is given as a slow injection into a vein (IV infusion) in a hospital or cancer clinic.
-
It is usually given once every 3 weeks, depending on the type of cancer.
-
Each session may take 30 to 60 minutes.
-
The dosage is determined by your body weight and overall health.
-
Only a cancer specialist should decide the dosage and treatment schedule.
-
You may need to stay for a short time after the infusion to monitor for any reactions.
It is not available as tablets or capsules and must be administered by a trained healthcare team.
Side Effects
Common Side Effects:
-
Tiredness
-
Skin rash or itching
-
Fever or chills
-
Feeling sick (nausea)
-
Joint or muscle pain
-
Cough or breathing discomfort
Serious Side Effects:
Tislelizumab boosts your immune system, so sometimes it may overreact and attack healthy parts of your body. Watch out for signs like:
-
Chest pain or shortness of breath
-
Severe diarrhea or belly pain
-
Yellow eyes or skin (may be liver-related)
-
Vision problems or confusion
-
Sudden muscle weakness
Report any unusual or ongoing symptoms to your doctor immediately.
Warnings
-
Not recommended during pregnancy or breastfeeding – it may harm the baby.
-
If you have a history of autoimmune diseases (like lupus, thyroid problems, or colitis), inform your doctor before starting.
-
You may need regular blood tests and scans during treatment to monitor your body’s response.
-
Inform your doctor about all other medications, including over-the-counter remedies and supplements.
-
Avoid vaccinations during treatment unless your doctor says it’s safe.
-
Do not start or stop taking this medicine without consulting your doctor.
Precautions
-
Stay well hydrated and eat a balanced diet to support your body.
-
Be alert for any new symptoms, even if they seem small — early reporting helps avoid serious problems.
-
Use sun protection, as skin may become sensitive.
-
Avoid crowded places if your white blood cell count is low (your doctor will inform you)
-
Keep all follow-up appointments, even if you feel fine.
Expert Tips
-
Always take someone with you during your infusion days in case you feel weak afterwards.
-
Keep a notebook or app to track your symptoms and energy levels.
-
Don’t compare your progress with others — response to this treatment varies from person to person.
-
Let your doctor know if you’re feeling mentally or emotionally low — support is available.
-
Wear comfortable clothes on infusion days and take snacks or water if allowed.
FAQs
Q1.
Tislelizumab is an immunotherapy used to treat certain types of cancers like classical Hodgkin lymphoma, non-small cell lung cancer, hepatocellular carcinoma, and esophageal cancer. It is usually prescribed when other treatments have failed or are not suitable. It works by activating your immune system to attack cancer cells. This therapy is given through an intravenous infusion.
Q2.
No, Tislelizumab is not chemotherapy. It belongs to a class of medications called immune checkpoint inhibitors. Unlike chemotherapy that kills both healthy and cancer cells, Tislelizumab boosts your immune system so it can target and destroy cancer more precisely.
Q3.
The response time can vary depending on the type of cancer and individual health conditions. Some patients may start seeing improvement within a few weeks, while for others it may take a couple of months. Regular scans and doctor evaluations will help determine how well the medicine is working.
Q4.
Yes, Tislelizumab is approved for the treatment of hepatocellular carcinoma, especially in patients who have previously been treated with Sorafenib. It helps the immune system recognize and fight liver cancer cells more effectively.
Q5.
Long-term use may lead to immune-related side effects like thyroid problems, adrenal gland issues, or inflammation in organs like the lungs and liver. Some side effects may persist even after treatment ends, so regular follow-up with your doctor is important.
References
Disclaimer
The drug information on this page is not a substitute for medical advice. It is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you can receive this treatment.






